CA Patent

CA2865526C — Nitric oxide releasing pharmaceutical compositions

Assigned to NVN Liquidation Inc · Expires 2020-06-23 · 6y expired

What this patent protects

The present invention generally relates to nitric oxide releasing pharmaceutical compositions and methods of using the same.

USPTO Abstract

The present invention generally relates to nitric oxide releasing pharmaceutical compositions and methods of using the same.

Drugs covered by this patent

berdazimer-sodium (BERDAZIMER SODIUM)

Patent Metadata

Patent number: CA2865526C
Jurisdiction: CA
Classification: —
Expires: 2020-06-23
Drug substance claim: No
Drug product claim: No
Assignee: NVN Liquidation Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.